Donald A. Kalkofen Protagonist Therapeutics, Inc (PTGX) insider trading activity
Donald A. Kalkofen is Chief Financial Officer of Protagonist Therapeutics, Inc. Currently has a direct ownership of 18,521 shares of PTGX, which is worth approximately $778,252. The most recent transaction as insider was on Feb 15, 2022, when has been sold 7,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
18.5K
0%
3M change
0%
12M change
Total Value Held
$778,252
DAK
Donald A. Kalkofen
Chief Financial Officer
Newark, CA